- Our Team
The U.S. Food and Drug Administration (FDA) approved a new drug to treat patients with Alzheimer’s disease, the first in nearly two decades,
… Read MoreResearchers from the Max Planck Institute for Metabolism Research in Cologne, the Cluster of Excellence for Ageing Research CECAD at the University
… Read MoreTestosterone therapy may reduce non-alcoholic fatty liver disease (NAFLD) in obese men with functional hypogonadism and type-2 diabetes, according to
… Read MoreA new analysis by researchers at Massachusetts General Hospital (MGH) offers new perspective on the disproportionate impact that the novel
… Read More